Trial Profile
Imaging Activated Macrophages in the Lungs
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Gallium-68-EC-2115 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Diagnostic use
- 13 Jan 2021 Status changed from suspended to discontinued as funding has ended and unable to recruit due to COVID 19. .
- 11 May 2020 Planned End Date changed from 31 Oct 2020 to 31 Oct 2021.
- 11 May 2020 Planned primary completion date changed from 30 Apr 2020 to 30 Apr 2021.